Aurobindo Pharma to buy Portugal-based Generis for Rs 969 cr

Acquisition includes Generis' facility in Amadora which can manufacture 1.2 bn tablets annually

Aurobindo Pharma on Saturday announced the acquisition of Generis Farmacêutica, which operates in Portugal, from Magnum Capital Partners for an all-cash deal of 135 million euros (Rs 969.3 crore).  

The deal will be completed through Aurobindo Pharma’s step-down subsidiary, Agile Pharma, Netherlands. It will include a manufacturing facility in Amadora, Portugal, which has the capacity to produce 1.2 billion tablets or capsules annually. 

The acquisition also consolidates Aurobindo’s footprint in Portugal. It portfolio currently consists of Aurovitas, Unipessoal LDA and Aurobindo Pharma-Portugal. Generis has a wide portfolio of products, with a major share in therapeutic areas such as cardiovascular, central nervous